Fan, B., & Wang, M. (2022). Ruxolitinib, a JAK1/2 Inhibitor as Treatment for Paraneoplastic Pemphigus: A Case Report. Acta Dermato-Venereologica, 102, adv00732. https://doi.org/10.2340/actadv.v102.1378